Showing results (181-190 of 1,286) with videos related to
Sort By:
Pageof 129
Urology|October 1, 1996
Histopathologic characterization of hereditary benign prostatic hyperplasiaC B Doehring, M G Sanda, A W Partin, et al.Urology|April 11, 2001
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendationsR Lieberman, W G Nelson, W A Sakr, et al.The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.The Journal of Urology|June 1, 1997
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, G J Gormley, et al.Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.Urology|January 14, 1999
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancerC F Eisenberger, P C Walsh, M A Eisenberger, et al.Surgical Endoscopy|May 5, 1999
Measurement of urinary N-acetyl-beta-D-glucosaminidase to assess renal ischemia during laparoscopic operationsS Micali, R I Silver, H S Kaufman, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1994
Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progressionR W Veltri, A W Partin, J E Epstein, et al.Pageof 129